Patents for C07K 19 - Hybrid peptides (29,428) |
---|
06/28/1995 | EP0513073B1 PROCESS FOR ENZYMATICAL CLEAVAGE OF RECOMBINANT PROTEINS BY MEANS OF IgA PROTEASES |
06/28/1995 | EP0460171B1 Cd3 specific recombinant antibody |
06/28/1995 | EP0432220B1 Vaccines and diagnostic assays for haemophilus influenzae |
06/27/1995 | US5427958 Detecting presence of autoantibodies in biological fluids; forming peptide complexes; in vitro; diagnosing lupus, autoimmune diseases |
06/27/1995 | US5427927 Modifying junction region between two components of fusion protein to form immunoglobulin A protease recognition site, cleaving, isolating component |
06/27/1995 | US5427908 Transforming cell with filamentous bacteriophage expression vector, culturing for expression and assembly of particle with antibody Fab fragment on coat, selecting encoding particle by binding to specific ligand, removing nonbinding particles |
06/22/1995 | WO1995016462A1 Method for antigen-specific immunoregulation by t-cell alpha chain |
06/22/1995 | DE4419264A1 Antigen, um Menschen und Tieren eine schützende Immunität gegen Wurminfektionen zu verleihen To confer antigen humans and animals protective immunity against worm infections |
06/22/1995 | CA2179018A1 Method for antigen-specific immunoregulation by t-cell alpha chain |
06/21/1995 | EP0658623A2 Attenuated herpesviruses, herpesviruses which include foreign DNA encoding an amino acid sequence and vaccines containing same |
06/21/1995 | EP0658567A1 Complexes between lectins and glycoproteins |
06/21/1995 | EP0658199A1 Production of heterodimer pdgf-ab by means of a bicistronic vector system in mammalian cells |
06/21/1995 | EP0658120A1 Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them |
06/21/1995 | EP0540588B1 A composition providing improved clearance of bioactive substances from the bloodstream |
06/20/1995 | US5426048 DNA encoding a fusion receptor for oncostatin M and leukemia inhibitory factor |
06/20/1995 | CA1336034C Biodegradable polypeptide and the use thereof for the gradual release of drugs |
06/15/1995 | WO1995016036A2 IFN-ηRECEPTOR β-CHAIN AND DERIVATIVES THEREOF |
06/15/1995 | WO1995015978A1 Pretargeting methods and compounds |
06/15/1995 | CA2178477A1 Pretargeting methods and compounds |
06/15/1995 | CA2177471A1 Ifn-.gamma.receptor .beta.-chain and derivatives thereof |
06/14/1995 | EP0657533A1 Monoclonal antibodies with high cytotoxicity against the human CD16 antigen, and bispecific monoclonal antibodies using such monoclonal antibodies and the CD30-HRS-3 antibody |
06/14/1995 | EP0657471A1 Anti ganglioside monoclonal antibodies and their use in the specific active immunotherapy of malignant tumours |
06/14/1995 | EP0657175A2 Vaccine comprising autologous epidermal growth factor and use thereof |
06/14/1995 | EP0656952A1 Cationic peptides and method for production |
06/14/1995 | EP0656950A1 Tat-derived transport polypeptides |
06/14/1995 | EP0656946A1 Immunoglobulins devoid of light chains |
06/14/1995 | EP0656944A1 Human melanocyte stimulating hormone receptor |
06/14/1995 | EP0656941A1 Methods for producing members of specific binding pairs |
06/13/1995 | CA1335879C Receptor membranes |
06/08/1995 | WO1995015331A1 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF |
06/08/1995 | WO1995015171A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN |
06/08/1995 | CA2177991A1 A 46 kd human milk fat globule antigen |
06/08/1995 | CA2177957A1 Specific fusion nucleic acids and proteins present in human t(2;5) lymphoma, methods of detection and uses thereof |
06/07/1995 | EP0656117A1 A methodology for selecting superagonists, antagonists and superantagonists of hormones whose receptor complex includes gp 130 |
06/07/1995 | EP0454783B1 Site specific in-vivo activation of therapeutic drugs |
06/06/1995 | CA1335796C Monoclonal antibodies and antigen for human non-small cell lung carcinomas |
05/31/1995 | EP0655626A1 Diagnostic assays for Alzheimer's disease |
05/31/1995 | EP0655501A1 HIV-2 virus variants |
05/31/1995 | CN1102983A Water-soluble medium molecular weight extractant from animal thymus gland |
05/30/1995 | US5420264 Non-human primate CD4 polypeptides, human CD4 molecules capable of glycosylation, fragments thereof, fusion proteins thereof, genetic sequences thereof, and the use thereof |
05/30/1995 | US5420019 Stable bactericidal/permeability-increasing protein muteins |
05/30/1995 | CA1335720C Detection of necrotic malignant tissue and associated therapy |
05/24/1995 | EP0654307A1 Method of two-dimensional aggregation and fixation of protein |
05/23/1995 | US5418135 Method of inhibiting binding of PDGF to a PDGF receptor by biosynthetic PDGF antagonists |
05/18/1995 | WO1995013293A1 Fas LIGAND, PART THEREOF, AND DNA CODING FOR THE SAME |
05/17/1995 | EP0652966A1 Method of increasing expression of viral proteins |
05/17/1995 | EP0652962A1 Expression of recombinant fusion proteins in attenuated bacteria |
05/17/1995 | EP0652901A1 Carboxy terminal il-6 muteins |
05/17/1995 | EP0652758A1 Diphtheria toxin vaccines |
05/17/1995 | EP0482185A4 Cell internalizable conjugates and complexes including intracellularly cleavable moieties |
05/16/1995 | US5416202 Such as gelonin, cysteine substitution |
05/16/1995 | US5415995 Diagnostic peptides of human papilloma virus |
05/11/1995 | WO1995012414A1 Novel modified pf4 compositions and methods of use |
05/11/1995 | CA2135330A1 Live vaccine vectors based on mycoplasma gallisepticum and nucleic acid probes therefrom |
05/10/1995 | EP0652231A1 NON-TOXIC RIBOSOME INACTIVATING PROTEINS (RIPs) WITH TWO CHAINS, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS |
05/10/1995 | EP0651818A1 Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
05/10/1995 | EP0651799A1 Fibrin binding domain polypeptides and uses and methods of producing same |
05/10/1995 | EP0651769A1 Leukaemia inhibitory factor-binding protein |
05/10/1995 | EP0651761A1 Method for modification of recombinant polypeptides |
05/10/1995 | EP0477231B1 Immunoactive peptides and antibodies and their use in anti-allergy treatment |
05/10/1995 | EP0366718B1 Monoclonal antibodies neutralizing hiv-1 |
05/10/1995 | CN1102438A Bifunctional variants of urokinase with improved fibrinolytic properties and thrombin-inhibiting activity |
05/09/1995 | US5413910 Measuring non-dystrophin proteins and diagnosing muscular dystrophy |
05/04/1995 | WO1995011987A1 Chimeric proteins including protease nexin-1 variants |
05/04/1995 | WO1994028132A3 Opioid receptors: compositions and methods |
05/03/1995 | EP0650596A1 Compositions and methods for regulating cellular signal transducing systems |
05/03/1995 | EP0650522A1 Novel cyclophilins, associating proteins and uses |
05/03/1995 | EP0650367A1 Blocking intercellular interactions with cd43 chimeric molecules |
05/03/1995 | EP0407544B1 Monoclonal antibody against protein c |
05/02/1995 | US5412073 Polypeptides and DNA coding therefor |
05/02/1995 | US5411941 Heterodimeric osteogenic factor |
05/02/1995 | US5411882 Cytokine which mediates inflammation |
05/02/1995 | US5411732 Preparing vaccines |
04/27/1995 | DE4336322A1 Method for increasing the solubility of fusion proteins of low solubility |
04/26/1995 | EP0649536A1 Assay for chagas' disease and reagents for its use |
04/26/1995 | EP0649470A1 Immediate early hsv-2 viral protein icp27 as vaccine |
04/26/1995 | EP0649435A1 Membrane-associated immunogens of mycobacteria |
04/26/1995 | EP0419513B1 Recombinant flagellin vaccines |
04/25/1995 | US5409815 DNA's encoding signal peptides |
04/25/1995 | CA1335361C Thrombus-targeted complexes of plasminogen activator and fibrin fragments |
04/25/1995 | CA1335358C Cks method of protein synthesis |
04/25/1995 | CA1335355C Anti-cpbii monoclonal antibody |
04/19/1995 | EP0648783A1 TNF inhibitors |
04/19/1995 | EP0648270A1 Cloning of gene encoding the gp28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications |
04/19/1995 | EP0648228A1 Bnp antibody and immunoassay using it |
04/19/1995 | EP0407392B1 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES |
04/12/1995 | EP0647277A1 Methods for using cks fusion proteins |
04/12/1995 | EP0647275A1 Cloning and expression of gonadotropin-releasing hormone receptor |
04/12/1995 | EP0647139A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
04/11/1995 | US5405945 DNA encoding reproductive hormones and expression using a minigene |
04/11/1995 | US5405758 DNA encoding the recombinant 40 kDA Dermatophagoides farinae allergen |
04/11/1995 | CA1335182C Cellulose binding fusion proteins |
04/11/1995 | CA1335180C Anti-thrombin-binding substance monoclonal antibodies, hybridomas producing same, as well as purification process and assay of thrombin-binding substance making use of said monoclonal antibodies |
04/05/1995 | EP0646644A2 Periplasmic membrane-bound system for detecting protein-protein interactions |
04/05/1995 | EP0646595A1 Nucleic acid binding oligomers having C-branches for therapy and diagnosis |
04/05/1995 | EP0646176A1 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
04/05/1995 | EP0646175A1 RECOMBINANT $i(PSEUDOMONAS) EXOTOXIN WITH INCREASED ACTIVITY |
04/05/1995 | EP0646174A1 Recombinant production of saporin-containing proteins |
04/05/1995 | EP0646173A1 Reagent for agglutination assays |
04/05/1995 | EP0646131A1 Serum amyloid a protein |